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     BSTRACT
A dog with combined atypical primary hypoadrenocorticism and primary hypothyroidism 
is described. The dog presented with waxing and waning, vague complaints since more than a 
year and had been treated with several drugs without complete resolution of signs. Based on 
the abnormalities on physical examination, blood examination and abdominal ultrasonography, 
atypical primary hypoadrenocorticism and primary hypothyroidism were diagnosed. 
Glucocorticoid supplementation was started and gradually tapered to maintenance rate because 
of polydipsia. Ten days later, levothyroxine supplementation was started at a very low dose and 
was gradually increased based on serum total thyroxine concentrations. The dog rapidly improved 
and recovered completely. Follow-up over a one-year period did not reveal new abnormalities. 
The presence of combined primary hypoadrenocorticism and primary hypothyroidism has been 
infrequently described in dogs and may resemble the Schmidt’s syndrome in humans. 
SAMENVATTING
In deze casus wordt een hond met gecombineerde atypische primaire hypoadrenocorticisme en 
primaire hypothyroïdie beschreven. De hond vertoonde reeds meer dan een jaar intermitterende, vage 
klachten. Ondanks meerdere medicamenteuze behandelingen vertoonde de hond geen volledige beter-
schap. Gebaseerd op de resultaten van het algemeen lichamelijk onderzoek, het bloedonderzoek en 
de abdominale echografie werd de hond gediagnosticeerd met primaire atypische hypoadrenocorti-
cisme en primaire hypothyroïdie. Een supplementatie met glucocorticoïden werd meteen opgestart 
en geleidelijk afgebouwd tot een onderhoudsdosis wegens polydipsie. Levothyroxinesupplementatie 
werd tien dagen nadien opgestart aan een zeer lage dosis en geleidelijk opgebouwd aan de hand van 
de totale thyroxine-serumconcentratie. De hond verbeterde snel en herstelde compleet. Controlecon-
sultaties gedurende meer dan een jaar toonden geen nieuwe abnormaliteiten aan. De combinatie van 
primaire hypoadrenocorticisme en primaire hypothyroïdie wordt niet vaak beschreven bij honden en 
vertoont gelijkenissen met het humane schmidtsyndroom. 
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INTRODUCTION
Addison’s disease, also called primary hypoadre-
nocorticism (HA), is a well-known, yet uncommon 
endocrinopathy, in which the adrenal glands are in-
capable of producing sufficient concentrations of 
steroids (glucocorticoids and/or mineralocorticoids) 
(Scott-Moncrieff, 2010; Baumstark et al., 2014). 
Female, young to middle aged dogs have a predis-
position for this disease (Sadek and Schaer, 1996; 
Thompson et al., 2007). The steroid deficiency can 
be due to destruction of the adrenal cortex (primary 
HA), mostly caused by an immune mediated pro-
cess, or due to pituitary dysfunction (secondary HA) 
(Kintzer and Peterson, 1997; Scott-Moncrieff, 2010). 
In a minority of cases with primary HA, only the zona 
fasciculata and zona reticularis and not the zona glo-
merulosa of the adrenal cortex are affected (Sadek 
and Schaer, 1996). Thereby, only the glucocorticoid 
production is impaired and no electrolyte abnormities 
are noted. This is referred to as atypical primary HA 
(Sadek and Schaer, 1996; Lifton et al. 1996,). Sodium 
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and potassium concentrations may also be normal in 
dogs with secondary HA due to adrenocorticotropic 
hormone (ACTH) deficiency as this deficiency does 
not impair mineralocorticoid production (Thompson 
et al., 2007). Atypical primary HA often causes vague 
complaints with a waxing and waning history, such 
as anorexia, vomiting, lethargy, depression, weak-
ness, weight loss, diarrhea and shaking or shivering 
(Melendez et al., 1996; Kintzer and Peterson, 1997; 
Thompson et al., 2007; Scott-Moncrief, 2010). On 
physical examination, non-specific abnormalities can 
be noticed or the physical examination can even be 
unremarkable (Thompson et al., 2007; Scott-Mon-
crief, 2015). Hematology and serum biochemistry 
results show only subtle clinicopathological changes, 
such as absence of a stress leukogram, mild non-re-
generative normocytic, normochromic anemia and 
hypoglycemia (Scott-Moncrief, 2010).
Dogs with clinical signs as described above, which 
do not react properly to symptomatic treatment, and 
do not show a stress leukogram, may be suspected 
of atypical HA and further testing is recommended. 
The gold standard to confirm the diagnosis of HA is 
an ACTH-stimulation test. Serum cortisol should be 
measured prior to and 60 to 90 minutes after ACTH 
administration (Scott-Moncrieff, 2010; Scott-Mon-
crieff, 2015a). To differentiate between primary and 
secondary HA, it is necessary to evaluate the pituitary 
function by evaluating ACTH-stimulated aldosterone 
concentrations or basal canine ACTH concentrations 
(Scott-Moncrieff, 2015a). 
 In primary HA, the destruction of the adrenal 
gland is mostly caused by an immune-mediated pro-
cess which, in rare cases, can occur concurrently 
with other immune-mediated endocrine disorders, 
such as hypothyroidism (HT), diabetes mellitus and 
hypoparathyroidism (Melendez et al., 1996; Scott-
Moncrieff, 2015a: Scott-Moncrieff, 2015b). In one 
study, 5 % of the 225 dogs with HA had concomitant 
endocrinopathies (Peterson, 1996). The presence of 
multiple endocrine disorders in dogs resembles poly-
glandular deficiency syndrome in humans (Neufeld et 
al., 1980). 
In the present case, a dog is presented that was 
diagnosed with a combination of atypical primary HA 
and primary HT compatible with a type II polyglandu-
lar syndrome, or the Schmidt’s syndrome in humans. 
Both atypical HA and Schmidt’s syndrome are rare 
and poorly characterized endocrinopathies in the dog. 
The purpose of this case report is to make this disease 
entity more familiar to practicing veterinarians.
 CASE REPORT
A six-year-old, female, neutered, mixed-breed dog 
of 26 kg was presented at the Faculty of Veterinary 
Medicine of Ghent University. The complaints had 
started more than a year before admission. Summa-
rized, the dog had a waxing and waning history of 
exercise intolerance, depression, drowsiness, partial 
anorexia, nausea, vomiting, ptyalism, diarrhea, poly-
dipsia, sneezing, nasal discharge, purulent ocular 
discharge, conjunctivitis, otitis externa due to malas-
sezia infection, hair loss and reduced skin and coat 
quality. Several physical and blood examinations had 
been performed by different veterinarians. Addition-
ally, urinalysis, serological tests, abdominal ultraso-
nography and echocardiography had been performed. 
According to the referring veterinarians, the physical 
examination did not reveal significant abnormali-
ties, except for mild generalized lymphadenopathy 
two months prior to admission. Serum biochemistry 
profiles revealed moderate azotemia, mild polyclonal 
hypergammaglobulinemia, very mild hyperkalemia, 
mild hypoglycemia, increased lactate dehydroge-
nase (LDH) and moderately increased creatine kinase 
(CK) (Table 1). On complete blood count (CBC), a 
mild microcytic, hypochromic anemia and lymphocy-
tosis were noticed (Table 1). Additional blood tests re-
vealed increased total thyroxine (TT4), increased Bor-
relia IgG and a negative Leishmania screening (direct 
agglutination test). Because of mild hypoglycemia, 
the insulin concentration was also evaluated to rule 
out insulinoma and this was below reference interval 
(6.3 mU/L (9.0-25.0)). The higher described abnor-
malities on serum biochemistry and CBC were not all 
consistently present. Complete urinalysis of free catch 
urine revealed isosthenuria (USG 1.014), rare calcium 
oxalate crystals and a negative culture. On abdomi-
nal ultrasonography, two months before admission, 
the kidneys were mildly decreased in size (5.4-5.9 
cm), but showed no other abnormalities. The adrenal 
glands had a normal shape, but were also small (3.9-
5.2 mm). There was a small amount of sediment in 
the urinary bladder and the medial iliac lymph nodes 
were prominent, but had a normal echogenicity. The 
peripheral lymph nodes were also ultrasonographi-
cally evaluated at that time and appeared mildly 
heterogeneous and more oval shaped. Cytology of 
the peripheral lymph nodes was suggestive for reac-
tive lymphadenopathy. For all previously summarized 
vague complaints, several symptomatic treatments 
were attempted (metoclopramide, nandrolonlaurinaat, 
vitamin B complex, ranitidine, metronidazole, cyclo-
sporine, enrofloxacine, meloxicam, doxycycline, pro-
biotics, Surolan® (miconazolenitrate, polymyxine-
B-sulfate, prednisoloneacetate), Aurizon® (marbo-
floxazine, clotrimazole, dexamethasone), maropitant, 
omeprazole). Most of these therapies had no effect or 
only yielded temporary, partial amelioration. Because 
of the positive Borrelia serology, doxycycline was 
given for a period of four weeks. However, as none 
of the treatments resulted in complete recovery and 
because of ongoing exercise intolerance, weakness 
and stiff gait, the dog was referred for a suspicion of a 
diffuse peripheral neuromuscular problem. 
On physical examination at the Department of 
Medicine and Clinical Biology of Small Animals, 
Faculty of Veterinary Medicine of Ghent University, 
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Table 1. Complete blood count, serum biochemistry profile, electrolyte concentrations, hormonology from the referring 
veterinarians expressed in ‘# weeks before admission’.
Variable  Units 45 8  7 6 4 Reference
   weeks weeks weeks weeks weeks interval
CBC        
 HCT % 41.4 / 35.8 / 36.2 43.0-59.0
 Hemoglobine mmol/L 8.66 / 7.60 / / 8.72-12.46
 MCV fl 63.2 / 60.4 / / 63.0-77.0
 MCH pg 21.2 / 20.6 / / 21.0-25.0
 WBC /µL 10610 / 12190 / / 6000-16000
 Segmented /µL     / 3000-11500
 neutrophils  4371 / 4888 / 
 Band neutrophils  0 / 0  / / 0-300
 Lymphocytes /µL 5379 / 6522  / / 1000-4800
 Monocytes /µL 329 / 280  / / <1350
 Basophils /µL 11 / 24  / / 0-100
 Eosinophils /µL 520 / 488 / / <1250
 Thrombocytes K/µL 274000 / 312000 / / 164000-510000
 Reticulocyte % 0.8 / 0.3  / / 
Biochemistry        
 Urea mmol/L 13.49 7.83 5.16 8.82 8.16 0.99-9.49
 Creatinine µmol/L 98.1 256.4  160.9 136.1 <60
 Total protein g/L 56 58 61 69 69 53-80
 Albumin g/L / 22.0 24.1 29 32 22-44
 Gamma globulines g/L / 11.3 11.7 12.3 10.4 3.6-9.1
 Glucose mmol/L 3.39 3.55 3.61 / / 3.05-4.99
 ALT U/L 65 / 122  / / <70
 AST U/L 69 / 69  / / <50
 ALP U/L 33 / 41  / / <111
 GGT U/L 5 / 7  / / <9
 LDH U/L / / 676  / 584 <605
 Bile acids U/L / / 8  /  <19
 CK U/L / / 1359  / 319 <331
Electrolytes         
 Sodium mmol/L / / 145  / / 143-154
 Potassium mmol/L / / 5.9  / / 4.2-5.6
 Calcium mmol/L / / 2.54  / 2.64 2.02-2.85
 Phosphorus mmol/L / / 1.08  / 1.87 0.96-1.88
Hormonology 
 TT4 nmol/L 60.63 / / / / 6.45-43.86
HCT: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, WBC: white blood cells, ALT: alanine transferase, AST: 
aspartate aminotransferase, ALP: alkaline phosphatase, GGT: Gamma globulinetranferase, LDH: lactate dehydrogenase, CK: creatinine kinase, 
TT4: total thyroxine. Increased values are colored in red, decreased values are colored in green.
the dog appeared slow, dull and depressive (Figure 1). 
Inspection of the dog revealed a stiff gait on the fore 
limbs and lethargy. A video of a walk with the owner 
also showed exercise intolerance and weakness. The 
heart rate (80 beats per minute), the respiration rate 
(20 per minute) and the temperature were all nor-
mal. Cardiovascularly, the dog had intermittently 
weak femoral pulses, a sinus arrhythmia, poorly filled 
jugular veins and prolonged capillary refill time. The 
presence of mild prominent peripheral lymph nodes, 
serous ocular discharge and seromucoid nasal dis-
charge, was also noticed. The abdominal palpation 
and rectal toucher were normal. The skin had an ery-
thematous aspect and there was mild to severe alo-
pecia on the neck, the ventral abdomen, the genital 
region and it was expanding distally and medially to 
the legs (Figures 1 and 2). On neurological examina-
tion, no abnormalities were present besides the abnor-
mal gait and lethargy. There were no indications for 
neck, back, bone, muscle and/or joint pain. Consider-
ing the prolonged and  multiple vague complaints and 
minimal abnormalities on neurological examination, 
metabolic problems needed to be considered first. 
The last bloodwork dated from one month before 
admission, and therefore, a complete blood examina-
tion was repeated (Table 2). The CBC showed mild non-
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regenerative microcytic anemia and mild thrombo- 
cytopenia. The serum biochemistry revealed mild 
azotemia and mildly increased creatine kinase. The 
serum electrolytes were within the reference interval. 
Because of the weak femoral pulses, the poorly filled 
jugular veins and prolonged capillary refill time, an 
echocardiography and electrocardiography (ECG) 
were performed. On echocardiography, there was a 
mild regurgitation at the level of the mitral- and tri-
cuspid valve. The ECG performed during echocar-
diography showed a sinus arrhythmia with occasional 
supraventricular premature complexes and a heart fre-
quency of 80 bpm. The fractional shortening was bor-
derline low (27% (30-35%)). Thoracic radiographs 
showed a mild diffuse broncho-interstitial pattern, 
probably related with the slightly increased body con-
dition of this dog. Because of the ongoing gastrointes-
tinal complaints, the abdominal ultrasonography was 
repeated, revealing bilateral small adrenal glands but 
no further abnormalities. Special attention was paid to 
signs of vascular thrombosis, considering the weak-
ness, the stiff gait and the weak femoral pulses, but 
these were not present. Urine was collected by ultra-
sound-guided cystocentesis and complete urinalysis 
only revealed urine specific gravity of 1.018.
Because of the subnormal fractional shortening, the 
bilateral alopecia and depressive behavior, HT was an 
important differential diagnosis but could not explain 
all clinical signs nor clinicopathological abnormali-
ties. Secondly, based on the sustained vague and non-
specific complaints, the bilateral small adrenal glands, 
the absence of a stress leukogram, the recurrent azo-
temia and non-regenerative microcytic anemia, HA 
was also considered to be an important possibility. 
Therefore, canine total thyroxine (TT4) and thyroid-
stimulating hormone (TSH) concentrations were mea-
sured and an ACTH-stimulation test was performed 
(Table 2). Before executing the ACTH-stimulation 
test, all referring veterinarians were contacted to con-
firm that no corticosteroids had been given to the dog 
in the last two months since these could influence the 
results of the ACTH-stimulation test. The decreased 
TT4 and increased TSH concentrations were consis-
tent with a diagnosis of primary HT. Additionally, the 
ACTH-stimulation test revealed HA. A diagnosis of 
atypical HA was made considering that the serum 
concentrations of sodium and potassium were within 
normal limits. To differentiate between atypical pri-
mary or secondary HA, serum aldosterone concentra-
tions were measured before and after ACTH-stimula-
tion. Both were very low, consistent with primary HA 
(Table 2). 
Initial treatment consisted of prednisolone and levo- 
thyroxine. The prednisolone (Prednisolone, Kela Lab-
oratories, Sint Niklaas, Belgium) was started at 0.14 
mg/kg, twice a day (BID) and was gradually tapered 
based on the clinical improvement of the dog and the 
known side-effects of prednisolone (Table 3). The ini-
tial dose of levothyroxine (Forthyron, Eurovet Ani-
mal Health BV, Bladel, the Netherlands) was 0.002 
mg/kg BID and this was increased every two weeks 
up to 0.008 mg/kg BID (Table 3). The levothyroxine 
supplementation was started ten days after the pred-
nisolone supplementation and at a very low dose be-
cause otherwise an Addison crisis may be induced 
(Scott-Moncrieff, 2015b). Two weeks after diagnosis, 
the dog’s clinical condition had improved markedly 
Figure 1. The dog at the day of presentation. Dull and 
depressive expression. Alopecia in the neck region, in 
the inguinal region and at the hind legs. General poor 
skin- and coat quality.
Figure 2. The affected genital region at the day of 
presentation. General poor skin- and coat quality and 
severe alopecia in the genital region. 
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Table 2. Complete blood count, serum biochemistry profile, electrolyte concentrations, hormonology. Day 0 is the day 
of admission at the Faculty of Veterinary Medicine. 
Variable  Units Day 0 2  1 2 3 6 9 Reference
    weeks month months months months months interval
CBC           
 HCT % 30.2 26.7 31 * 38.1 / / 50.1 37.3-61.7
 Hemoglobine g/dl 11.2 10.1 / 13.6 / / 17.8 13.1-20.5
 MCV fL 56.6 57.9 / 62.4 / / 64.9 61.6-73.5
 MCH pg 21 21.9 / 22.3 / / 23.1 21.2-25.9
 Reticulocyte K/µL 18.2 29.5 / 63.5 / / 42.5 10-110
 WBC 109   g/L 9.3 11.6 / 10.28 / / 8.09 5.05-16.76
 Neutrophils  109   g/L 3.6 7.66 / 7.51 / / 6.35 2.95-11.64
 Lymphocytes 109   g/L 4.76 3.08 / 2.18 / / 1.25 1.05-5.1
 Monocytes 109   g/L 0.32 0.65 / 0.42 / / 0.35 0.16-1.12
 Basophils 109   g/L 0 0 / 0.01 / / 0.01 0-0.1
 Eosinophils 109   g/L 0.62 0.07 / 0.16 / / 0.13 0.06-1.23
 TBC K/µL 135 372 / 329 / / 212 148-484 
 
Biochemistry         
 Urea mmol/L 13.7 / / / / / 7.1 2.5-9.6
 Creatinine µmol/L 227 / / / / / 152 44-159
 Total protein g/L 64 / / / / / 67 52-82
 Albumin g/L 26 / / / / / 37 23-40
 Globulines g/L 38 / / / / / 30 25-45
 Glucose mmol/L 3.89 / / / / / 6.00 3.05-4.99
 ALT U/L 61 / / / / / 93 10-100
 ALP U/L 19 / / / / / 78 23-212
 CK U/L 454 / / / / / / 10-200 
 
Electrolytes           
 Sodium mmol/L 152 156 157 155 158 158 158 144-160
 Potassium mmol/L 5.4 5.5 4.6 4.8 4.2 4.2 4,1 3.5-5.8
 Chloride mmol/L 120 116 117 118 119 120 118 109-122
 Calcium mmol/L  2.51 / / / / 2.50 1.98-3
 Phosphorus mmol/L  1.61 / / / / 1.03 0.81-2.2 
 
Hormonology          
 TT4 nmol/L <6.45 16.77 / 52.89 / / 43.86 6.45-43.86
 TSH ng/ml 6.43 / / / / / / 
 ACTH stim. nmol/L
 Test 
  Cortisol pre  < 3 / / / / / /
  Cortisol post  < 3 / / / / / /
 Aldosterone pmol/L <27.74 
HCT: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, WBC: white blood cells, TBC: thrombocythes ALT: alanine trans-
ferase, AST: aspartate aminotransferase, ALP: alkaline phosphatase, CK: creatinine kinase, TT4: total thyroxine, TSH: thyroid stimulating hormone, ACTH: 
adrenocorticotropic hormone. * means: microhematocrit or packed cell volume. Increased values are colored in red, decreased values are colored in green.
(e.g. less depressed, able to make long walks, good 
appetite, no more nausea, etc.). Nevertheless, there 
were new complaints of polyuria and polydipsia (pu/
pd). The coat and skin quality was still poor and even 
worsened at the beginning of therapy. There were 
complaints of excessive hair loss and cold intoler-
ance (shivering) (Figure 3). Laboratory tests showed 
a normalized TT4 value and stable electrolyte values, 
but a moderate microcytic anemia persisted (Table 2). 
Because of pu/pd, the prednisolone dose was tapered 
to 0.1 mg/kg BID and two weeks later to once a day 
(SID) (Table 3). Follow-up appointments were sched-
uled after one, two, three, six and nine months. The 
general condition of the dog kept improving and was 
considered normal after two months. During follow-
up, no new abnormalities were noticed on physical 
examination. Three weeks after diagnosis, all cardio-
vascular parameters (heart rate, capillary refill time, 
pulse quality) normalized. However, on follow-up, 
ECG a lone atrial fibrillation (LAF) with a ventricular 
response rate of 104 beats per minute was noticed. No 
underlying structural cardiac disease could be identi-
fied. The first improvement of coat quality and quan-
tity was seen after two months. After nine months, 
the haircoat completely recovered (Figure 4). Blood 
examinations were frequently repeated during a 
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nine-month follow-up period showing normalization 
of all initial abnormalities. Serum electrolytes always 
remained within normal limits (Table 2). After nine 
months, a complete blood work was repeated, which 
revealed no abnormalities (Table 2). After one year, 
a control ECG did not show any more abnormalities 
either. 
DISCUSSION 
HA is a well-described endocrinopathy. Neverthe-
less, the atypical primary form is not that well known 
by practicing veterinarians and is more challenging to 
diagnose. In cases with a chronic history of waxing 
and waning complaints, without major abnormalities 
on blood examination, especially with an absent stress 
leukogram, which do not improve permanently on 
symptomatic treatment, the suspicion of HA should 
arise (Scott-Moncrieff, 2015a). In the present case, 
the dog had already been suffering from these vague 
complaints for more than a year. Several symptom-
atic treatments were given but gave only mild, tem-
porary improvement. HA is mostly seen in young to 
middle-aged, female dogs; so the dog in this case fits 
with the typical signalment. Moreover, many of the 
abnormalities, which were seen on physical and blood 
examinations and on medical imaging (e.g. dull and 
depressive expression, weakness, intermittently weak 
femoral pulses, mild generalized lymphadenopathy, 
mild microcytic non-regenerative anemia, mild azote-
mia, bilateral small adrenal glands) were all findings 
that may be indicative for HA. An ACTH-stimulation 
test was performed after contacting all referring vete- 
rinarians to ensure no corticosteroids were given 
two months prior to admission. As this was not the 
case, the test was reliable and confirmative for HA. 
A less expensive test to rule out HA is the basal cor-
tisol concentration (bcc) (Lennon et al., 2007). This 
test has a high negative predictive value (100%) and 
so, dogs with bcc’s higher than 2µg/dL are highly 
unlikely to have HA (Lennon et al., 2007). It is im-
portant to realize that values below 2µg/dL are not 
sufficient to diagnose HA, and an ACTH-stimulation 
test is always required to confirm the diagnosis (Len-
non et al., 2007). In the dog described, the bcc was 
not measured but an ACTH-stimulation test was im-
mediately performed. After confirmation of HA, the 
next step was to differentiate between primary and 
secondary HA by evaluating endogenous ACTH or 
ACTH-stimulated aldosterone concentrations. In the-
ory, the measurement of basal ACTH concentration is 
more accurate than measuring aldosterone concentra-
tions to differentiate between primary and secondary 
HA (Scott-Moncrieff, 2015a). Unfortunately, plasma 
ACTH measurement is not practical, because specific 
and strict guidelines must be followed for sample col-
lection and handling. Endogenous ACTH is very la-
bile, it has a short half-life, is not thermostable and 
should not come into contact with glass (Behrend et 
al., 2013). In contrast, aldosterone is more stable, spe-
cific handling precautions are not needed and assays 
are more widely available (Sieber-Ruckstuhl, 2006). 
Therefore, it was decided to measure ACTH-stimu-
lated aldosterone concentrations in the present case. 
Aldosterone secretion should be impaired in case of 
primary HA and should be normal with secondary 
HA. Dogs with atypical primary HA are suspected 
of having normal aldosterone concentrations due to 
the sparing of the zona glomerulosa (Baumstark et al., 
2014). In this case, the decreased aldosterone concen-
trations before and after ACTH administration led to 
the diagnosis of atypical primary HA. These low aldo-
sterone concentrations are contradictory to the normal 
sodium and potassium concentrations measured in this 
dog (Table 2). It has been assumed that normal aldo-
sterone concentrations are mandatory to maintain nor-
mal electrolyte values as seen with primary atypical 
HA (Baumstark et al., 2014; Scott-Moncrieff, 2015a). 
Figure 3. The dog one and a half month after initiation 
of therapy. Worsening of skin- and coat quality and the 
alopecia is more severe and more generalized. At that 
time, the dog suffered from excessive hair loss and cold 
intolerance.
Figure 4. The dog nine months after initiation of therapy. 
The skin- and coat quality is completely normalized.    
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It is difficult to underpin this assumption because in 
most reported cases, aldosterone concentrations were 
not evaluated (Scott-Moncrieff, 2015a). However, in 
a recent study describing aldosterone concentrations 
in dogs with HA, four dogs with atypical primary HA 
had low baseline- and ACTH- stimulated aldosterone 
concentrations (Baumstark et al., 2007). These find-
ings and the laboratory results of the present case, 
imply that there have to be other mechanisms which 
may explain the maintenance of normal sodium and 
potassium concentrations. Some of the possible hy-
potheses include increased dietary sodium intake, 
increased renin concentrations (compensated failure 
of the zona glomerulosa), partial sparing of the zona 
glomerulosa, mutation of the ACTH receptor gene, 
disparity in the rate of destruction of glucocorticoid 
and mineralocorticoid secreting cells and influence of 
concurrent disease such as HT (Oelkers, 1992; Frank 
et al., 2013). In this case, the owner was not aware of 
a higher sodium intake and the dog had been partially 
anorectic for a long time. Other hypotheses, and par-
ticularly the influence of concurrent HT, could not be 
excluded. Nonetheless, it can be concluded that the 
appearance of normal sodium and potassium values 
does not always reflect a normal function of the zona 
glomerulosa and that further research on large scale 
is required. 
In this case, a concurrent diagnosis of primary 
hypothyroidism (HT) was made, based on low TT4 
and high TSH concentrations. When the dog became 
ill, that was forty-five weeks before admission, with 
complaints of partial anorexia, vomiting, diarrhea 
and weakness, blood examinations were performed 
and showed increased canine TT4 value (Table 1). 
This increased TT4 value may have been caused 
by anti-thyroid hormone antibodies (Thacker et al., 
1992). These antibodies may occur in 2% of dogs 
with clinical signs of lymphocytic thyroiditis and in 
15% of dogs with HT (Nachreiner et al., 2002). Anti-
thyroid hormone antibodies and TSH were not mea-
sured in this dog. Therefore, it is uncertain if the dog 
had already been suffering from clinical HT at that 
time point. Nevertheless, it was certainly suffering 
from a polyendocrine disorder at the day of presenta-
tion. The developing time between the first and the 
second endocrinopathies may vary with an average 
of four months (Blois, 2011). In this dog, both dis-
eases were diagnosed simultaneously, so it was im-
possible to determine which disease had developed 
first. The appearance of multi-endocrinopathy is rare 
in the dog, with a prevalence of only -5% of the dogs 
with HA (Peterson 1996; Scott-Moncrieff, 2015a). 
An immune-mediated etiology is suspected in these 
polyglandular syndromes (Scott-Moncrieff, 2010; 
Blois, 2011; Scott-Moncrieff, 2015a; Scot-Moncrieff, 
2015b). The most common combinations of immune-
mediated endocrine disorders in dogs with multiple 
endocrinopathies have been reported to be HT and 
diabetes mellitus (28%) and HT and HA (23%) (La-
than and Tyley, 2005; Blois, 2011). The presence of 
multiple endocrine disorders in dogs resembles poly-
glandular deficiency syndrome in humans, which is 
further divided in three types (Neufeld et al., 1980). 
The combination of primary HA, primary HT and/
or insulin-dependent, diabetes mellitus is known as 
type II polyglandular autoimmunity or Schmidt’s syn-
drome. This syndrome has already been described (18 
cases) in small animal veterinary medicine (Bowen 
et al., 1986; Bartges and Nielson, 1992; Kooistra et 
al., 1995, Lifton et al., 1996; Melendez et al., 1996, 
Smallwood and Barsanti, 1995; Adissu and foster, 
2015). In ten of the eighteen reported cases, an atypi-
cal HA was described in combination with HT. The di-
agnosis of a polyglandular syndrome may be assumed 
by demonstrating circulating antiadrenal and anti-
thyroid antibodies or by histology of glandular biop- 
sies (Blois et al., 2011). One canine case with both 
anti-adrenal and anti-thyroid antibodies has been re-
ported (Bowen et al., 1986). In two cases, autopsy and 
histology revealed an immune-mediated glandular 
destruction (Kooistra et al., 1995; Adissu and Foster, 
2010). In the present case, antibodies were not mea-
sured. Since the dog was doing perfectly well, biop-
sies for histology were not advised. The signalment, 
clinical history, the abnormalities found on physical 
and blood examinations (typical of primary HA and 
primary HT) and on medical imaging in combination 
with the immediately positive response to treatment 
all indicated polyendocrinopathy, more specifically 
the Schmidt’s syndrome. 
Table 3. Schematic representation of the posology of the initiated treatment after diagnosis.
Time Drug Time Drug
 Prednisolone (mg/kg)   Levothyroxine(mg/kg)
D1 0.14 BID D1 0.002                 BID 
D14 0.1   BID D14 0.004                 BID
D30 0.1   SID D30 0.006                 BID  
  D 44 0.008                 BID
D 60 0.1 SID D 60 0.008                 BID
D1: first day of treatment; SID: once daily; BID: twice daily
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The treatment of atypical HA, without electrolyte 
abnormalities, initially consists of the supplementa-
tion of glucocorticoids alone (0.1 to 0.22 mg/kg/day 
prednisolone) (Scott-Moncrieff, 2015a). The therapy 
should lead to rapid, total, clinical improvement, and 
the dose should be gradually tapered to maintenance 
rate (Scott-Moncrieff, 2015a). Previously, it had 
been assumed that the supplementation of mineralo-
corticoids was unnecessary because the function of 
the zona glomerulosa, which produces mineralocor-
ticoids, was thought not to be affected (Kintzer and 
Peterson, 1997; Scott-Moncrieff, 2015a). However, 
knowing that serum aldosterone concentrations do 
not always remain within normal limits, this theory is 
questioned (Baumstark et al., 2014). In human medi-
cine, the decision to supplement mineralocorticoids or 
not is based on the measurement of renin concentra-
tions (Stewart and Krone, 2011). In veterinary medi-
cine however, the measurement of renin concentration 
is not widely available. Therefore, it is often advised 
to only supplement glucocorticoids. Moreover, rapid 
and complete clinical improvement is seen in dogs 
treated with only glucocorticoid supplementation. In 
addition, drugs for mineralocorticoid supplementa-
tion might be costly and not always easily available 
(Baumstark et al., 2014; Scott-Moncrieff, 2015a). In 
the present case, prednisolone therapy was started at 
0.14 mg/kg BID and gradually tapered, because of pu/
pd, until 0.1 mg/kg SID (Table 3). After two weeks 
of therapy, the dog was already doing much better 
and after eight weeks, the general condition of the 
dog was considered normal. Nonetheless, at the first 
recheck appointment, a lone atrial fibrillation (LAF) 
was noticed on the control ECG. This LAF was not 
present on the day of admission. LAF may be associ-
ated with endocrinopathies, such as (atypical) HA and 
HT, although a cause-and-effect relationship has not 
been clearly established yet (Gerritsen et al., 1996; 
Takemura et al., 2002; Riesen and Lombard., 2006). 
In this case, it was difficult to determine which one of 
the two endocrinopathies had been the possible cause 
of the LAF. However, HT seems to be more likely be-
cause the treatment for HT had only been started since 
one week, and the HT had not yet been controlled at 
the time of LAF diagnosis. One year later the clinical 
and laboratory findings were completely normalized 
and LAF was not present anymore.
A good follow-up of dogs with atypical primary 
HA is mandatory. Blood examinations have to be re-
evaluated regularly because of the risk of progression 
to complete adrenal failure (Scott-Moncrieff, 2015a). 
The destruction of the adrenal cortex is thought to be 
caused by an immune-mediated adrenalitis, which 
may progress to the zona glomerulosa of the adrenal 
cortex (Schaer et al., 1986; Lifton et al., 1996; Lathan 
and Tyley, 2005). This progression leads to comple-
mentary mineralocorticoid deficiency, and additional 
supplementations with mineralocorticoids to the pred-
nisolone supplementation will be required (Scott-
Moncrieff, 2010). However, this progression is dif-
ficult to predict in the individual patient. Some dogs 
do not progress during years of monitoring and oth-
ers suddenly do (Lifton et al., 1996; Thomson et al., 
2007; Scott-Moncrieff, 2010; Baumstark et al., 2014). 
A retrospective case study showed 12.5% chance of 
progression (lifton et al., 1996). Moreover, most of 
the dogs that progress, do so within the first year after 
diagnosis (Rogers et al., 1981; Lifton et al., 1996a nor-
mal Na:K ratio (> 27; Thompson et al., 2007). There-
fore, electrolyte concentrations should be monitored 
every one to three months for at least the first year 
after diagnosis (Kintzer and Peterson, 1997; Scott-
Moncrieff, 2010; Scott-Moncrieff, 2015a). Owners 
of these dogs should adequately be informed, so they 
can recognize the first clinical signs of mineralocorti-
coid deficiency and contact the veterinarian (Baum-
stark et al., 2014), because rapid supplementation of 
mineralocorticoids may be of vital importance (Scott-
Moncrieff, 2015a). The dog in this case was regularly 
reevaluated for more than a year but the electrolytes 
always stayed within normal limits. 
In addition to the HA, this dog was also diagnosed 
with HT and thus with a polyglandular syndrome. In 
these cases, it is important to treat every glandular de-
ficiency separately (Baumstark et al., 2014). Although 
an immune-mediated etiology is suspected, it is not 
advised to start immunosuppressive drug therapy in 
these syndromes (Scott-Moncrieff, 2015a). Further-
more, it should be borne in mind that the treatment 
of one glandular deficiency might influence the other. 
For example, supplementation with thyroid hormones 
in untreated Addison patients, may precipitate an Ad-
dison crisis because the normalization of the slower 
metabolism associated with HT leads to increased 
corticosteroid demands (Bowen et al., 1986; Scott-
Moncrieff, 2015a). In the present case, a very low 
dose of levothyroxine was therefore started only ten 
days after the prednisolone supplementation was initi-
ated. The levothyroxine dose was gradually increased 
to avoid worsening of the cardiac problems and HA 
(Table 3). Although the dog was doing clinically better 
within short term, initially, the skin and coat problems 
worsened and it took nine months before skin and coat 
could be considered normal again. Nonetheless, this 
response and reaction to levothyroxine therapy can be 
considered normal for a hypothyroid dog. It has been 
documented that initially, the hair coat may appear to 
worsen (Credille et al., 2001), and that it may take 
several months of therapy for complete regrowth and 
progression of skin quality (Scott-Moncrieff, 2015b).
CONCLUSION
The dog of the present case was suffering from 
waxing and waning, vague complaints for more than 
a year before it was diagnosed with atypical primary 
HA and primary HT. Atypical HA is more challeng-
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ing to diagnose than typical HA, since the typical 
abnormal sodium-to-potassium concentration ratio is 
absent. This emphasizes the fact that normal serum 
electrolytes are not a reliable parameter to exclude 
HA. Moreover, in case of a dog with a chronic history 
of vague complaints, with an absent stress leukogram 
and which does not react properly on symptomatic 
treatment, high suspicion should arise for (atypical) 
HA. An unexpected finding in this case was the de-
creased aldosterone concentrations despite the normal 
electrolytes, as described in other cases. Further re-
search in atypical HA patients is required.
In addition, the dog was also diagnosed with pri-
mary HT. The polyendocrinopathy, which was seen 
in this dog has seldom been described in veterinary 
medicine and is similar to a polyglandular syndrome 
type II (Schmidt’s syndrome) described in humans. 
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